(Q40788985)

23 September 2017

0 references

"Is there an emerging need for new antifungals?". (English)

1 reference

23 September 2017

1

John R Perfect

1 reference

23 September 2017

language of work or name

English

0 references

publication date

17 February 2016

1 reference

Expert Opinion on Emerging Drugs

23 September 2017

published in

1 reference

23 September 2017

volume

21

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

129-131

1 reference

Emerging fungal threats to animal, plant and ecosystem health

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Multiple emergences of genetically diverse amphibian-infecting chytrids include a globalized hypervirulent recombinant lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Invasion dynamics of white-nose syndrome fungus, midwestern United States, 2012-2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Infectious Disease. How to bolster the antifungal pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Hidden killers: human fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Higher plant diversity promotes higher diversity of fungal pathogens, while it decreases pathogen infection per plant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

The changing epidemiology of healthcare-associated candidemia over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Combination antifungal therapy for invasive aspergillosis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints an

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2016.1155554

10.1517/14728214.2016.1155554

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference